SCHEMBL23327775

SCHEMBL23327775

FCCOCCOCCOC1CCN(c2ccc(-c3nc4ccccc4s3)cn2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.42
RAB9A P51151 6/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
CDK5 Q00535 1/20 0.38
CDK5R1 Q15078 1/20 0.38
DGAT1 O75907 1/20 0.38
KCNH2 Q12809 1/20 0.38
AURKA O14965 1/20 0.37
FLT4 P35916 1/20 0.37
SCD O00767 1/20 0.37
KDM4E B2RXH2 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 3/20 0.36
TP53 P04637 2/20 0.36
HSD17B10 Q99714 2/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
DRD2 P14416 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21462384 0.90 NPC1 (0.42) NPC1RAB9AMEN1KMT2ACDK5
SCHEMBL23327790 0.82 NPC1 (0.50) NPC1RAB9AMEN1KMT2ACDK5
SCHEMBL21462716 0.81 NPC1 (0.42) NPC1RAB9AMEN1KMT2ACDK5
SCHEMBL21462350 0.81 NPC1 (0.47) NPC1RAB9AMEN1KMT2ACDK5
SCHEMBL21462585 0.80 NPC1 (0.45) NPC1RAB9AMEN1KMT2ACDK5
SCHEMBL20783868 0.80 PDE10A (0.38) DGAT1KCNH2SCDPDE10A
SCHEMBL21462334 0.78 NPC1 (0.52) NPC1RAB9AMEN1KMT2ACDK5
SCHEMBL23327544 0.77 NPC1 (0.47) NPC1RAB9AMEN1KMT2ACDK5
SCHEMBL21462440 0.77 PDE10A (0.49) NPC1RAB9AMEN1KMT2ACDK5
SCHEMBL19341609 0.77 RAB9A (0.51) NPC1RAB9AMEN1KMT2ACDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210138092-A1 SELECTIVE LIGANDS FOR TAU AGGREGATES CBD SOLUTIONS AB (SE) 2021-05-13 US claimed
US-12636385-B2 Selective ligands for tau aggregates SENTONIX, INC. (US) 2026-05-26 US disclosed
US-20210138092-A1 SELECTIVE LIGANDS FOR TAU AGGREGATES CBD SOLUTIONS AB (SE) 2021-05-13 US disclosed
US-20210138092-A1 SELECTIVE LIGANDS FOR TAU AGGREGATES CBD SOLUTIONS AB (SE) 2021-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210138092-A1 SELECTIVE LIGANDS FOR TAU AGGREGATES MAPT, PSEN1, PSEN2 NPC1 558/4885RAB9A 1319/4885MEN1 1382/4885
US-12636385-B2 Selective ligands for tau aggregates MAPT, PSEN2, PSEN1 NPC1 242/4885RAB9A 1472/4885MEN1 1162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.